National mobilization seeks to maintain Anvisa's RDC 660/2022 and prevent risks to the continuity of treatments for thousands of patients

In Deusa Cast, experts discuss the possibility of storing cannabis-based products in Brazil. Regulatory advances, legal obstacles, and logistical impacts were debated in light of RDCs 660 and 327

In Deusa Cast, experts discuss the possibility of storing cannabis-based products in Brazil. Regulatory advances, legal hurdles, and logistical impacts were debated in light of RDCs 660 and 327

According to Marcelo Polacow Bisson, excluding pharmacies' manipulation leads to lack of assistance; Anvisa's proposed text on the Cannabis regulation is also criticized for bypassing procedural rites

Curitiba welcomes its first exclusive medicinal cannabis pharmacy, in a market that grew from R$ 38.5 million in 2022 to R$ 237.8 million in 2025, while Paraná accounts for only 2.4% of sales, indicating great potential in the state with 11 million inhabitants

Resumption of Anvisa review and STJ deadline for cultivation define the sector's direction in the first quarter of the year

Pharmaceutical company Ephar has obtained registration for its Cannabidiol in two concentrations, 50 mg/mL and 100 mg/mL, which will be marketed in a low THC content drop solution

How the pharmaceutical industry ensures quality and safety in cannabis-based products sold in Brazil

Gustavo Palhares believes that regulatory review could streamline prescription, expand access, and raise technical requirements in the medical cannabis sector

Lecture led by specialist will address scientific updates, clinical use, and regulation of cannabinoid therapies in Dentistry during the event in São Paulo

Planning to travel at the end of the year and using medical cannabis? Learn about the required documents, how to transport the medication, and what precautions to take in Brazil and abroad

Pharmaceutical company Farmausa Life Science has obtained registration for its Cannabidiol in two concentrations, 20 mg/mL and 100 mg/mL, with low THC content

Cannten's extract with 71.33 mg/mL expands medicinal treatment options in the country and receives authorization for commercialization

Endogen's extract expands the portfolio of options for medicinal treatments and already has sanitary authorization for commercialization

Live broadcast will be held on the Agency's YouTube channel; board will have a strategic role in topics such as cannabis regulation in Brazil

The President emphasized the responsibility of the appointees and reinforced the importance of the agencies for the country's development

The event brings together experts, companies, and authorities to discuss regulatory advances, research, and innovation in cannabis-based therapies, connecting the entire public and private sector

With applications ranging from the pharmaceutical industry to construction, the sector is being structured with machinery, research, and investments, and is expected to grow even before the definitive regulation of cultivation in Brazil; the consultant discussed the topic during an interview at Andav 2025

Published by Anvisa, new resolution expands the scope of the network of analytical laboratories and reinforces the quality control of cannabis-based products in the country

Learn about the differences between CBD and THC, their therapeutic uses in various diseases, and understand the legal landscape of medical cannabis in Brazil, which is advancing with regulations that expand safe access for thousands of patients